Female Sexual Health Treatment in Miami

Understanding Female Sexual Dysfunction

Female sexual dysfunction (FSD) encompasses a range of persistent, distressing conditions that interfere with sexual desire, arousal, orgasm, or comfort. Despite affecting an estimated 40% of women at some point in their lives, FSD remains underdiagnosed and undertreated — in part because many women are reluctant to raise the topic with their healthcare providers, and in part because the medical community has historically given less attention to female sexual health than to male sexual health.

At Rewind Anti-Aging of Miami, we take female sexual health seriously. We provide a confidential, judgment-free environment where you can discuss your concerns openly, and we offer a range of evidence-based treatments that address the hormonal, neurological, and physical dimensions of female sexual function.

Types of Female Sexual Dysfunction

Hypoactive Sexual Desire Disorder (HSDD)

HSDD is the most common form of female sexual dysfunction. It is characterized by a persistent, distressing lack of sexual desire — not simply a temporary dip in libido caused by stress or fatigue, but a meaningful decline that causes personal or relational distress. HSDD affects an estimated 1 in 10 women and can occur at any age, though it becomes more common during perimenopause and menopause as hormonal levels shift.

Arousal Difficulties

Female sexual arousal disorder involves difficulty achieving or maintaining physical arousal — even when desire is present. This can manifest as insufficient genital blood flow, reduced vaginal lubrication, decreased clitoral sensitivity, or an inability to become physically "ready" for intercourse despite feeling mentally interested. Arousal difficulties are often connected to hormonal changes, certain medications (particularly SSRIs and hormonal contraceptives), or vascular factors.

Vaginal Dryness and Painful Intercourse

Vaginal dryness is one of the most common complaints during perimenopause and menopause, affecting up to 50% of postmenopausal women. As estrogen levels decline, the vaginal tissue becomes thinner, less elastic, and produces less lubrication. This condition, known as vaginal atrophy or genitourinary syndrome of menopause (GSM), can make intercourse uncomfortable or painful (dyspareunia), leading many women to avoid sexual activity altogether.

Anorgasmia

Anorgasmia is the persistent difficulty or inability to reach orgasm despite adequate sexual stimulation and arousal. It can be primary (never having experienced orgasm), secondary (having previously been orgasmic but losing the ability), situational (occurring only in certain contexts), or generalized (occurring in all situations). Causes include hormonal changes, medication side effects, pelvic floor dysfunction, neurological factors, and psychological barriers.

The Hormonal Connection: Perimenopause, Menopause, and Beyond

Hormones play a central role in female sexual function, and the hormonal shifts of perimenopause and menopause profoundly affect desire, arousal, lubrication, and orgasm.

• Estrogen — maintains vaginal tissue health, lubrication, and blood flow to the genital area. Declining estrogen causes vaginal atrophy, dryness, and reduced clitoral sensitivity.
• Testosterone — women produce testosterone from the ovaries and adrenal glands, and it is a primary driver of sexual desire. Testosterone levels decline steadily with age, and by menopause, most women have approximately half the testosterone they had in their 20s.
• Progesterone — affects mood, sleep quality, and overall sense of well-being. Progesterone fluctuations and eventual decline during perimenopause can indirectly impair sexual function through anxiety, sleep disruption, and mood changes.
• DHEA — a precursor hormone that converts to both estrogen and testosterone. DHEA levels peak in the mid-20s and decline progressively, contributing to the overall hormonal decline that affects sexual health.

This is why sexual health treatment at Rewind Anti-Aging often begins with a comprehensive hormone evaluation. Addressing the hormonal foundation makes targeted sexual health treatments significantly more effective.

Treatment Options at Rewind Anti-Aging of Miami

Libido Cream / Scream Cream

Our custom-compounded topical cream is one of the most popular and effective treatments for female arousal and orgasm difficulties. Applied directly to the clitoral and vaginal area approximately 30 minutes before sexual activity, it contains a combination of vasodilating and nerve-sensitizing ingredients:

• Aminophylline — a phosphodiesterase inhibitor that increases blood flow to genital tissue by relaxing smooth muscle in blood vessel walls
• L-Arginine — an amino acid that serves as a precursor to nitric oxide, the molecule that triggers blood vessel dilation and engorgement
• Additional compounded ingredients tailored to individual needs

The cream increases genital blood flow, enhances nerve sensitivity, and improves the ability to achieve arousal and orgasm. It works locally — at the site of application — with minimal systemic effects.

Oxytocin Nasal Spray

Oxytocin is the hormone naturally released during physical touch, intimacy, and orgasm. It promotes emotional bonding, reduces anxiety, and enhances the subjective experience of pleasure and connection. Supplemental oxytocin delivered via nasal spray approximately 30 to 60 minutes before sexual activity can:

• Enhance feelings of emotional closeness and intimacy
• Reduce performance anxiety and self-consciousness
• Increase physical arousal and sensitivity
• Improve orgasm intensity and satisfaction

Oxytocin nasal spray is particularly effective for women whose sexual difficulties are connected to stress, anxiety, emotional disconnection, or difficulty "getting out of their head" during intimacy.

PT-141 (Bremelanotide / Vyleesi)

PT-141 is a peptide that works through an entirely different mechanism than any other sexual health treatment. It activates melanocortin receptors in the brain, directly increasing sexual desire and arousal at the neurological level. Unlike treatments that target genital blood flow or hormones, PT-141 addresses the desire component of sexual function — the part that makes you want to be intimate in the first place.

PT-141 is FDA-approved under the brand name Vyleesi specifically for premenopausal women with HSDD. It is administered as a subcutaneous injection approximately 45 to 60 minutes before anticipated sexual activity. Common side effects include nausea (which typically diminishes with repeated use), flushing, and headache. Learn more on our PT-141 page.

Vitamin E Cream

For women experiencing vaginal dryness and tissue thinning, topical Vitamin E cream provides moisturizing and tissue-nourishing benefits. Vitamin E is an antioxidant that supports cell membrane integrity, promotes tissue healing, and improves the moisture content and elasticity of vaginal tissue. It can be used as a daily moisturizer and before intercourse to reduce friction and discomfort.

Hormone Optimization

When sexual dysfunction is rooted in hormonal imbalance — as it frequently is during perimenopause and menopause — optimizing hormone levels can produce transformative improvements in desire, arousal, lubrication, and overall sexual satisfaction. Our female hormone replacement therapy program addresses:

• Estrogen replacement for vaginal health, lubrication, and tissue integrity
• Testosterone optimization for libido and desire
• Progesterone balancing for mood, sleep, and overall well-being
• DHEA supplementation when indicated

Our Approach to Female Sexual Health

1. Confidential consultation — we discuss your symptoms, medical history, medications, hormonal status, and relationship context in a private, judgment-free setting. We understand that these conversations require trust and sensitivity.
2. Comprehensive evaluation — blood work to assess estradiol, testosterone, progesterone, DHEA-S, thyroid function, and other markers. Understanding your hormonal picture is essential for effective treatment.
3. Personalized treatment plan — we match treatments to your specific symptoms and underlying causes. Some women benefit from topical treatments alone. Others need hormone optimization. Many benefit from a combination approach.
4. Follow-up and adjustment — sexual health treatment requires fine-tuning. We follow up to assess results, adjust treatments, and ensure you are achieving meaningful improvement.